cytokine release syndrome

Have You Tested Positive For COVID-19? This is What Happens Next.

Four Months After Itolizumab ‘Trial’ and 9 Million Infections Later – No Progress

Review: Why Are Blood Clots Such a Major Problem in Severe COVID-19?

DCGI Rejects Mylan’s Request to Waive Phase 3 Trials for COVID-19 Drug

Itolizumab for COVID-19: Who Benefits When the Drug Regulator Is Opaque?

Is Biocon’s Itolizumab Good News? Hard to Tell, Thanks to the Bad Science.